Effector Therapeutics Inc (EFTR) — Free Cash Flow Generation Index

Latest as of June 2020: 1.00x

Effector Therapeutics Inc (EFTR) has a Free Cash Flow Generation Index of 1.00x as of June 2020. Free cash flow of $11.98 Million represents 1% of operating cash flow ($11.98 Million). Read EFTR liabilities breakdown for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$11.98 Million
USD

Operating Cash Flow

$11.98 Million
USD

Capital Expenditures

$0.00
USD

Effector Therapeutics Inc Free Cash Flow Generation Index (2020–2020)

Historical FCF Generation Index trend for Effector Therapeutics Inc across 1 annual periods. Explore EFTR capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Effector Therapeutics Inc (2020–2020)

Year-by-year Free Cash Flow Generation Index for Effector Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Effector Therapeutics Inc.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.99x $13.68 Million $13.84 Million $154.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).